Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile Business Wire - Tue Jul 7, 5:30AM CDT

New 6-month data supports COMP360’s potential to establish a new standard of care in TRD Data from positive COMP006 Phase 3 trial demonstrates durable...

CMPS : 13.60 (-2.61%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Thu Jul 2, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 13.60 (-2.61%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity FinancialNewsMedia - Tue Jun 30, 8:00AM CDT

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 6.63 (+6.42%)
CMPS : 13.60 (-2.61%)
GHRS : 27.20 (+1.30%)
JNJ : 259.10 (-1.63%)
DFTX : 48.45 (+6.91%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity GlobeNewswire - Tue Jun 30, 8:00AM CDT

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 6.63 (+6.42%)
CMPS : 13.60 (-2.61%)
GHRS : 27.20 (+1.30%)
JNJ : 259.10 (-1.63%)
DFTX : 48.45 (+6.91%)
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer GlobeNewswire - Mon Jun 29, 6:30AM CDT

WALTHAM, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment...

CMPS : 13.60 (-2.61%)
KLRA : 21.01 (-3.45%)
SPRO : 2.12 (-2.30%)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - Fri Jun 5, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under...

CMPS : 13.60 (-2.61%)
Compass Pathways Elects Kathleen Tregoning to Board of Directors Business Wire - Thu May 28, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to...

CMPS : 13.60 (-2.61%)
SPRO : 2.12 (-2.30%)
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026 Business Wire - Tue May 26, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies...

CMPS : 13.60 (-2.61%)
MarketBeat.com
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins MarketBeat - Thu May 21, 1:03AM CDT

Compass Pathways (NASDAQ:CMPS) executives said the company remains on track to target a fourth-quarter New Drug Application filing for COMP360, its synthetic psilocybin treatment candidate for treatment-resistant...

CMPS : 13.60 (-2.61%)
Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 Business Wire - Thu May 14, 5:30AM CDT

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the RBC...

CMPS : 13.60 (-2.61%)

Barchart Exclusives

SMCI Stock Likely to Reverse from Oversold Levels as DCBBS Gains Growth Traction Barchart - 1 hour ago
Supermicro announced a new partnership with Red Hat. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.